salofalk granules mesalazine 500mg modified release granules sachet
dr falk pharma australia pty ltd - mesalazine, quantity: 500 mg - granules, modified release - excipient ingredients: colloidal anhydrous silica; purified talc; povidone; aspartame; titanium dioxide; methacrylic acid copolymer; magnesium stearate; triethyl citrate; microcrystalline cellulose; carmellose sodium; simethicone; citric acid; hypromellose; flavour - salofalk granules are indicated for the treatment of acute ulcerative colitis of mild to moderate severity, and for the maintenance of remission and/or the long term treatment of ulcerative colitis.
salofalk mesalazine 1g enteric coated tablet, blister pack
dr falk pharma australia pty ltd - mesalazine, quantity: 1 g - tablet, enteric coated - excipient ingredients: povidone; microcrystalline cellulose; croscarmellose sodium; colloidal anhydrous silica; calcium stearate; hypromellose; methacrylic acid copolymer; purified talc; titanium dioxide; iron oxide yellow; macrogol 6000 - salofalk tablets are indicated in the treatment of acute episodes and maintenance of remission of: i. mild to moderate ulcerative colitis; and ii. crohn?s ileitis and colitis
salofalk enemas mesalazine 2g/60ml enema bottle
dr falk pharma australia pty ltd - mesalazine, quantity: 2000 mg - enema - excipient ingredients: sodium benzoate; carbomer 934p; disodium edetate; potassium acetate; potassium metabisulfite; xanthan gum; purified water - salofalk enemas are indicated in the treatment of acute ulcerative colitis of mild to moderate severity and for the maintenance treatment of ulcerative colitis.
salofalk enemas mesalazine 4g/60ml enema bottle
dr falk pharma australia pty ltd - mesalazine, quantity: 4000 mg - enema - excipient ingredients: sodium benzoate; carbomer 934p; disodium edetate; potassium acetate; potassium metabisulfite; xanthan gum; purified water - salofalk enemas are indicated in the treatment of acute ulcerative colitis of mild to moderate severity and for the maintenance treatment of ulcerative colitis.
salofalk enemas mesalazine 2g/30ml enema bottle
dr falk pharma australia pty ltd - mesalazine, quantity: 2000 mg - enema - excipient ingredients: disodium edetate; potassium acetate; purified water; xanthan gum; potassium metabisulfite; carbomer 934p; sodium benzoate - salofalk enemas are indicated in the treatment of acute ulcerative colitis of mild to moderate severity and for the maintenance treatment of ulcerative colitis.
pentasa slow release tablets 1 gram
ferring pharmaceuticals ltd - mesalazine - tablets slow release - mesalazine 1 g - mesalazine - mild to moderate ulcerative colitis. crohn's disease.
pentasa slow release granules 4 g.
ferring pharmaceuticals ltd - mesalazine - granules - mesalazine 4000 mg - mesalazine - mild to moderate ulcerative colitis or crohn's disease.
pentasa slow release granules 1 gr.
ferring pharmaceuticals ltd - mesalazine - granules - mesalazine 1 g - mesalazine - treatment of mild to moderate ulcerative colitis or crohn's disease.
asacol 800
tradis gat ltd - mesalazine - tablets enteric coated - mesalazine 800 mg - mesalazine - " ulcerative colitis:-for the treatment of mild to moderate acute exacerbations. -for the maintenance of remission.crohn's disease:-for the treatment of acute episodes."
asacol mesalazine 1.6 g enteric coated tablet blister pack
chiesi australia pty ltd - mesalazine, quantity: 1.6 g - tablet, enteric coated - excipient ingredients: microcrystalline cellulose; sodium starch glycollate type a; hypromellose; colloidal anhydrous silica; magnesium stearate; macrogol 6000; methacrylic acid copolymer; triethyl citrate; glyceryl monostearate; polysorbate 80; sodium hydroxide; maize starch; iron oxide red; iron oxide yellow; monobasic potassium phosphate - asacol is indicated for the treatment of mild to moderate ulcerative colitis and maintenance of remission in adults.